Live Breaking News & Updates on Merrimack Pharmaceuticals Price Performance

Stay updated with breaking news from Merrimack pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gary L. Crocker Buys 2,000 Shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Stock

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) insider Gary L. Crocker purchased 2,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was bought at an average cost of $12.52 per share, with a total value of $25,040.00. Following the purchase, the insider now owns 133,105 shares in the […] ....

United States , United Kingdom General , United Kingdom , Garyl Crocker , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Price Performance , Merrimack Pharmaceuticals Company Profile , Geode Capital Management , News Ratings For Merrimack Pharmaceuticals Daily , Blackrock Inc , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Securities Exchange Commission , Get Free Report , Exchange Commission , Avenue Partners , Street Corp , Capital Management , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Insider Trading , Nsider Trades ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Lowered by StockNews.com

Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday. Merrimack Pharmaceuticals Price Performance Shares of MACK stock traded down $0.08 during trading hours on Friday, reaching $11.80. 209,960 shares of the stock were exchanged, compared to its average volume of […] ....

United States , United Kingdom , Merrimack Pharmaceuticals , News Ratings For Merrimack Pharmaceuticals Daily , Boothbay Fund Management , Merrimack Pharmaceuticals Price Performance , Wittenberg Investment Management Inc , Merrimack Pharmaceuticals Inc , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Free Report , Street Group , Street Corp , Investment Management , Fund Management , Madison Avenue Partners , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Stocknews Com ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Rating Increased to Hold at StockNews.com

Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Saturday. Merrimack Pharmaceuticals Price Performance Merrimack Pharmaceuticals stock opened at $12.50 on Friday. The stock has a market cap of $178.25 million, a P/E ratio of -104.17 and […] ....

United Kingdom , United States , United Kingdom General , Eric Andersen , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Company Profile , Blackrock Inc , Securities Exchange Commission , Institutional Trading Of Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Price Performance , Millennium Management , Barclays Plc , Merrimack Pharmaceuticals Inc , Get Rating , Director Eric Andersen , Exchange Commission , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Stocknews Com ,